0001127602-24-013566.txt : 20240429
0001127602-24-013566.hdr.sgml : 20240429
20240429164957
ACCESSION NUMBER: 0001127602-24-013566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240425
FILED AS OF DATE: 20240429
DATE AS OF CHANGE: 20240429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Jason R
CENTRAL INDEX KEY: 0001845677
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40097
FILM NUMBER: 24892055
MAIL ADDRESS:
STREET 1: 667 MADISON AVENUE
STREET 2: C/O CORVEX MANAGEMENT LP
CITY: NEW YORK
STATE: NY
ZIP: 10065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc.
CENTRAL INDEX KEY: 0001830214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 872652913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (877) 442-5362
MAIL ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20210210
FORMER COMPANY:
FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20201027
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-04-25
0001830214
Ginkgo Bioworks Holdings, Inc.
DNA
0001845677
Kelly Jason R
C/O GINKGO BIOWORKS HOLDINGS
27 DRYDOCK AVENUE
BOSTON
MA
02210
1
1
See remarks
0
Stock Option
2.50
2024-04-25
4
A
0
5000000
0
A
2034-04-25
Class A Common Stock
5000000
5000000
D
The options are subject both to time-based and performance-based vesting criteria (the "Founder Options"). The performance-based vesting is tied to the achievement of four specified stock price hurdles within a five-year period, with 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $5.00, 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $7.50, 20% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $10.00 and the remaining 60% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $12.50. If any of the performance-based criteria are achieved during the five-year performance period, the awards will vest on the five-year anniversary of the grant date, subject to the Reporting Person's continued employment with Ginkgo on such anniversary.
CEO & Founder
/s/ Karen Tepichin, Attorney-in-Fact
2024-04-29